Ticker

No recent analyst price targets found for PSYCF.

Latest News for PSYCF

Psyched Wellness Announces Closing of Private Placement and Shares for Debt Transaction and Resignation of a Director

Toronto, Ontario--(Newsfile Corp. - March 20, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces the closing of (i) the first tranche of its non-brokered private placement (the "Offering") for gross proceeds of C$859,653.47, led by Gotham Green Fund…

Newsfile Corp • Mar 20, 2026
Psyched Wellness Announces Private Placement for Proceeds of up to C$1,719,306.94

Toronto, Ontario--(Newsfile Corp. - March 11, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is excited to announce that it has entered into a non-binding memorandum of terms (the "Term Sheet") with Gotham Green Fund…

Newsfile Corp • Mar 11, 2026
Psyched Wellness Sells Out of First Run of Calmer and Announces New Production Run

Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) ("Psyched" or the "Company"), a life sciences company dedicated to developing and commercializing products derived from the Amanita Muscaria mushroom, is pleased to announce a key commercial milestone for its newest product, Calmer.

Newsfile Corp • Jan 15, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for PSYCF.

No Senate trades found for PSYCF.

No House trades found for PSYCF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top